Skip to content
healthcare.dev

TOFACITINIB CITRATE

NDC 68254-5011, TOFACITINIB CITRATE, tablet, film coated, from CONCORD BIOTECH LIMITED.

Product NDC
68254-5011
Status
Listed
Labeler
CONCORD BIOTECH LIMITED
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218821
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68254-5011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE8.08 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
68254-5011-16825450110128 TABLET, FILM COATED in 1 BOTTLE (68254-5011-1)
68254-5011-26825450110260 TABLET, FILM COATED in 1 BOTTLE (68254-5011-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6c33e5b4-4843-4a80-a4f8-435bfceddc2a

Use it

Look up 68254-5011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68254-5011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68254-5011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.